期刊文献+

通降解毒方药物血清干预胃癌细胞增殖的实验研究 被引量:2

Experimental Study of Serum Containing Tongjiangjiedu Decoction on Proliferation of Gastric Cancer Cell
下载PDF
导出
摘要 目的通过观察通降解毒方药物血清对胃癌MKN-45细胞增殖的影响,以期佐证其临床抑制肿瘤生长的作用。方法制备通降解毒方药物血清,MKN-45细胞随机分为空白对照组、空白血清组、通降解毒方血清组、5-Aza-CdR组,培养24、48、72 h后观察胃癌细胞的形态变化,CCK8法测定胃癌细胞活性。结果通降解毒方血清组、5-Aza-CdR组均能抑制MKN-45细胞的增殖,与空白对照组比较,差异有统计学意义。结论通降解毒方药物血清能抑制体外胃癌细胞的增殖,从体外实验的角度可以解释其临床抗肿瘤的效果。 Objective : To observe the effects of serum containing Tongjiangjiedu Decoction on proliferation of gastric cancer cell MKN--45 and to study its mechanism of anticancer in clinical. Methods:After Tongjiangjiedu Decoction-containing serum being prepared,MKN-45 cells were divided into the blank control group,the blank serum group,the Tongiiangjiedu Decoction-containing serum group and the 5-Aza-CdR group. Morphological changes observed after gastric cancer cells in culture 24,45,72h. Gastric cell viability was determined by CCK8. Results:Cell proliferation was obviously inhibited in the Tongjtangjiedu Decoction-containing serum group and the 5-Aza-CdR group. There were significant differences among above groups and the blank control group. Con- clusion:Serum containing Tonjgianjgiedu Decoction could suppress gastric cancer cell proliferation.Its clinical an- ti-tumor effect can be explained from the perspective of in vitro experiments.
出处 《中国中医急症》 2012年第8期1254-1254,1281,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 贵州省科技厅联合基金资助(黔科合LS字[2011]010)
关键词 通降解毒方 胃癌细胞 细胞增殖 血清药理学 Tongjiangjiedu Decoction Gastric cancer cell Cell proliferation Serum pharmacology
  • 相关文献

参考文献3

二级参考文献21

  • 1李桂玲,归绥琪,朱德厚,陈松华,叶阳.掌叶半夏有效提取物单独或与顺铂联合对体外培养宫颈癌HeLa细胞的作用[J].复旦学报(医学版),2007,34(6):869-872. 被引量:8
  • 2秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 3杨宗辉,尹建元,魏征人,颜炜群.天南星提取物诱导人肝癌SMMC-7721细胞凋亡及其机制的实验研究[J].中国老年学杂志,2007,27(2):142-144. 被引量:37
  • 4Massague J. G1 cell-cycle control and cancer. Nature. 2004;432(7015):298-306. 被引量:1
  • 5Mizoshita T, Kataoka H, Kubota E, et al. Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil[J]. Int J Clin Oncol, 2008, 13(4) :373-376. 被引量:1
  • 6Sasak T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignances based on evidence [ J ]. Jpn J Cancer Chemother, 2000,27 ( 20 ) : 166. 被引量:1
  • 7Ishitsuka H. Capecitabine : preclinicalpharmacology studies [ J ]. Invest New Drugs, 2000, 18(4) : 343-354. 被引量:1
  • 8Terashima M, Fujiwara H,Takagane A, et al. Role of thymidine phosphorylase and dihydropyrimidine dehydogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients[J]. Eur J Cancer, 2002, 38(18) : 2375-2381. 被引量:1
  • 9Kang HJ, Chang HM, Kim TW, et al. A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer [ J ]. Br J Cancer,2008,98 ( 2 ) :316-322. 被引量:1
  • 10Cunningham D, Starling N, Rao S, et al. Capecitabine and oxali- platin for advanced esophagogastric cancer [ J ]. N Engl J Med, 2008,358( 1 ) :36-46. 被引量:1

共引文献58

同被引文献34

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部